Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:52 pm Purchase |
2024-12-31 | 13G | Momentus Inc. MNTS |
Armistice Capital, LLC | 179,458 9.990% |
179,458 (New Position) |
Filing History |
| 2025-02-14 5:52 pm Purchase |
2024-12-31 | 13G | MacroGenics, Inc. MGNX |
Armistice Capital, LLC | 6,276,000 9.990% |
18,000 (+0.29%) |
Filing History |
| 2025-02-14 5:51 pm Purchase |
2024-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
Armistice Capital, LLC | 339,767 9.990% |
38,779 (+12.88%) |
Filing History |
| 2025-02-14 5:50 pm Purchase |
2024-12-31 | 13G | LM Funding America, Inc. LMFA |
Armistice Capital, LLC | 404,151 9.990% |
106,811 (+35.92%) |
Filing History |
| 2025-02-14 5:50 pm Purchase |
2024-12-31 | 13G | Pasithea Therapeutics Corp. KTTA |
Armistice Capital, LLC | 133,787 9.990% |
17,907 (+15.45%) |
Filing History |
| 2025-02-14 5:49 pm Purchase |
2024-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
Armistice Capital, LLC | 9,468,000 5.920% |
1,268,000 (+15.46%) |
Filing History |
| 2025-02-14 5:49 pm Unchanged |
2024-12-31 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 6,800,000 6.750% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:44 pm Sale |
2024-12-31 | 13G | 5E Advanced Materials Inc. FEAM |
Armistice Capital, LLC | 174,208 5.820% |
-42,314 (-19.54%) |
Filing History |
| 2025-02-14 5:44 pm Purchase |
2024-12-31 | 13G | Evaxion Biotech A/S EVAX |
Armistice Capital, LLC | 639,329 9.990% |
639,329 (New Position) |
Filing History |
| 2025-02-14 5:44 pm Purchase |
2024-12-31 | 13G | Sphere 3D Corp. ANY |
Armistice Capital, LLC | 2,583,718 9.990% |
2,583,718 (New Position) |
Filing History |
| 2025-02-14 5:43 pm Purchase |
2024-12-31 | 13G | Enlivex Therapeutics Ltd. ENLV |
Armistice Capital, LLC | 2,208,000 9.750% |
32,116 (+1.48%) |
Filing History |
| 2025-02-14 5:42 pm Purchase |
2024-12-31 | 13G | Ekso Bionics Holdings, Inc. EKSO |
Armistice Capital, LLC | 2,250,021 9.990% |
57,308 (+2.61%) |
Filing History |
| 2025-02-14 5:42 pm Sale |
2024-12-31 | 13G | Edible Garden AG Incorporated EDBL |
Armistice Capital, LLC | 79,793 9.990% |
-2,298 (-2.80%) |
Filing History |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 276,422 9.990% |
90,211 (+48.45%) |
Filing History |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | Danimer Scientific, Inc. DNMR |
Armistice Capital, LLC | 171,761 5.500% |
171,761 (New Position) |
Filing History |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF |
Armistice Capital, LLC | 478,547 9.990% |
70,437 (+17.26%) |
Filing History |
| 2025-02-14 5:40 pm Purchase |
2024-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Armistice Capital, LLC | 841,695 9.990% |
619,040 (+278.03%) |
Filing History |
| 2025-02-14 5:39 pm Purchase |
2024-12-31 | 13G | Cosmos Health Inc. COSM |
Armistice Capital, LLC | 2,508,013 9.990% |
359,825 (+16.75%) |
Filing History |
| 2025-02-14 5:38 pm Purchase |
2024-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 5,216,445 9.990% |
642,699 (+14.05%) |
Filing History |
| 2025-02-14 5:36 pm Sale |
2024-12-31 | 13G | Iveda Solutions, Inc. IVDA |
Armistice Capital, LLC | 139,603 4.990% |
-96,660 (-40.91%) |
Filing History |